7/24/2013

Duke University researchers developed a gel made partly of chemically modified laminin protein to improve cell therapies that treat painful disc degeneration in the spine. The gel is intended to keep therapeutic cells from moving away from the injection site. The NIH-funded research is still in preclinical stages.

Related Summaries